Revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Evogene Ltd. (EVGN)
Price$0.5379Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9M | $5.6M | $3.0M | $1.7M | $930,000 | $1.0M | $753,000 | $1.7M | $3.4M | $6.5M | $11.1M |
| Gross profit | −$241,000 | $3.2M | $1.5M | $766,000 | $163,000 | $466,000 | $419,000 | $295,000 | $536,000 | $901,000 | $2.9M |
| Gross margin | −6.25% | 57.32% | 50.03% | 45.73% | 17.53% | 44.81% | 55.64% | 16.89% | 15.85% | 13.78% | 25.82% |
| Research & development | $8.0M | $12.5M | $16.2M | $20.8M | $21.1M | $17.3M | $15.8M | $14.7M | $17.0M | $16.4M | $14.4M |
| Operating expenses | $13.8M | $22.0M | $23.7M | $27.7M | $31.1M | $25.3M | $21.6M | $20.3M | $22.5M | $22.0M | $20.8M |
| Operating income | −$14.0M | −$18.8M | −$22.2M | −$26.9M | −$31.0M | −$24.8M | −$21.2M | −$20.0M | −$21.9M | −$21.1M | −$17.9M |
| Operating margin | −364.24% | −337.17% | −745.51% | −1,608.42% | −3,328.28% | −2,385.96% | −2,810.89% | −1,144.19% | −649.13% | −322.46% | −161.03% |
| EBITDA | −$12.9M | −$17.4M | −$20.9M | −$25.4M | −$29.7M | −$23.0M | −$18.8M | −$18.0M | −$19.8M | −$18.8M | −$15.5M |
| EBITDA margin | −334.54% | −312.41% | −701.91% | −1,518.09% | −3,188.28% | −2,213.65% | −2,492.83% | −1,028.56% | −585.68% | −287.61% | −139.17% |
| Net income | −$7.8M | −$18.1M | −$26.0M | −$29.8M | −$30.4M | −$26.2M | −$19.1M | −$20.8M | −$20.8M | −$19.6M | −$17.2M |
| Net profit margin | −203.14% | −323.72% | −870.36% | −1,781.73% | −3,273.66% | −2,519.81% | −2,538.51% | −1,191.30% | −616.33% | −299.57% | −154.67% |
| Basic EPSper basic share | $1.08 | -$2.90 | -$5.20 | -$6.44 | -$6.90 | -$8.30 | -$7.00 | -$8.10 | -$8.10 | -$7.70 | -$6.80 |
| Diluted EPSper diluted share | $1.08 | -$2.90 | -$5.20 | -$6.44 | -$6.90 | -$8.30 | -$7.00 | -$8.10 | -$8.10 | -$7.70 | -$6.80 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
HRT FINANCIAL LP | 107.2K |
RECANATI LEON | 83.89K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 80.08K |
CITADEL ADVISORS LLC | 50.53K |
XTX Topco Ltd | 19.4K |
UBS Group AG | 10.79K |
Daytona Street Capital LLC | 9.25K |
ELDAD YARON | 4.1K |
BNP PARIBAS FINANCIAL MARKETS | 2.83K |
MORGAN STANLEY | 1.29K |
Federation des caisses Desjardins du Quebec | 500 |
OSAIC HOLDINGS, INC. | 100 |
SHP Wealth Management | 65 |
SBI Securities Co., Ltd. | 62 |
ROYAL BANK OF CANADA | 42 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data